Joseph C. Galante - Dec 1, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Dec 1, 2022
Transactions value $
$3,447
Form type
4
Date filed
12/23/2022, 04:10 PM
Previous filing
Dec 23, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $151 +65 +0.12% $2.33 55.9K Dec 1, 2022 Direct F1
transaction CPIX Common Stock Purchase $150 +65 +0.12% $2.31 55.9K Dec 2, 2022 Direct F1
transaction CPIX Common Stock Purchase $142 +65 +0.12% $2.19 56K Dec 5, 2022 Direct F1
transaction CPIX Common Stock Purchase $142 +65 +0.12% $2.19 56.1K Dec 6, 2022 Direct F1
transaction CPIX Common Stock Purchase $142 +65 +0.12% $2.18 56.1K Dec 7, 2022 Direct F1
transaction CPIX Common Stock Purchase $142 +65 +0.12% $2.19 56.2K Dec 8, 2022 Direct F1
transaction CPIX Common Stock Purchase $140 +65 +0.12% $2.15 56.3K Dec 9, 2022 Direct F1
transaction CPIX Common Stock Purchase $139 +65 +0.12% $2.14 56.3K Dec 12, 2022 Direct F1
transaction CPIX Common Stock Purchase $262 +120 +0.21% $2.18 56.4K Dec 13, 2022 Direct F1
transaction CPIX Common Stock Purchase $265 +120 +0.21% $2.21 56.6K Dec 14, 2022 Direct F1
transaction CPIX Common Stock Purchase $134 +60 +0.11% $2.24 56.6K Dec 15, 2022 Direct F1
transaction CPIX Common Stock Purchase $222 +100 +0.18% $2.22 56.7K Dec 16, 2022 Direct F1
transaction CPIX Common Stock Purchase $553 +250 +0.44% $2.21 57K Dec 19, 2022 Direct F1
transaction CPIX Common Stock Purchase $462 +200 +0.35% $2.31 57.2K Dec 20, 2022 Direct F1
transaction CPIX Common Stock Purchase $400 +180 +0.31% $2.22 57.4K Dec 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.